Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
David Goldberg MD, MSCE

David Goldberg MD, MSCE

Associate Professor of Medicine; Associate Professor of Public Health Sciences, Division of Digestive Health and Liver Diseases, Department of Medicine, University of Miami Miller School of Medicine, Miami, Florida

Dr. David Goldberg is an Associate Professor of Medicine in the Division of Digestive Health and Liver Diseases and Associate Professor of Medicine at the University of Miami Miller School of Medicine. Dr. Goldberg completed fellowships in gastroenterology and then transplant hepatology at the University of Pennsylvania, after which he was a faculty member from 2013-2019 before joining the faculty at the University of Miami Miller School of Medicine in 2019. Dr. Goldberg is a transplant hepatologist who focused most of his time conducting epidemiology and health services research on topics related to chronic and end-stage liver disease, organ allocation and transplantation, and organ donation. He is currently the PI/Co-PI of two R01 grants funded from the NIDDK/NIH focused on developing new models to estimate the survival benefit of liver transplantation, and to develop better models to predict outcomes of kidney and liver allografts, a U01 from the NIDDK to perform a multi-center trial of transplanting kidneys from hepatitis C-infected donors into hepatitis C-negative patients, and a U01 to participate in the NIDDK-sponsored Liver Cirrhosis Network. Dr. Goldberg has published more than 150 peer-reviewed publications including first-author papers in the New England Journal of Medicine and JAMA.


Dr. Goldberg receives grant support from Gilead and AbbVie.